Metastatic prostate cancer‐associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6. Issue 6 (31st January 2018)
- Record Type:
- Journal Article
- Title:
- Metastatic prostate cancer‐associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6. Issue 6 (31st January 2018)
- Main Title:
- Metastatic prostate cancer‐associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6
- Authors:
- Jiang, Xianhan
Huang, Yiqiao
Liang, Xue
Jiang, Funeng
He, Yongzhong
Li, Tian
Xu, Guibin
Zhao, Haibo
Yang, Weiqing
Jiang, Ganggang
Su, Zhengming
Jiang, Lingke
Liu, Leyuan - Abstract:
- Abstract : Background: P62 (also named sequestosome‐1, SQSTM1) is involved in autophagy regulation through multiple pathways. It interacts with autophagosomes‐associated LC3‐II and ubiquitinated protein aggregates to engulf the aggregates in autophagosomes, interacts with HDAC6 to inhibit its deacetylase activity to maintain the levels of acetylated α‐tubulin and stabilities of microtubules to enhance autophagosome trafficking, and regulates autophagy initiation and cell survival. We performed immunohistochemistry staining of P62 in prostate tissues from prostate cancer patients and found that levels of P62 in patients with prostate adenocarcinomas (PCA) are significantly higher than those in patients with benign prostate hyperplasia (BPH). High levels of P62 predict high tumor grade and high intensity of metastasis. Methods: We created prostate cancer cell lines stably overexpressing P62 and then suppress the expression of P62 in the cell line stably overexpressing P62 with CRISPR technology. Cell proliferation assay with crystal violet, cell migration assay, cell invasion assay, Western blot analysis, and confocal fluorescent microscopy were conducted to test the impact of altered levels of P62 on the growth, migration, invasion, epithelial‐to‐mesenchymal transition, autophagy flux, HDAC6 activity, and microtubular acetylation of cancer cells. Results: P62 increased the levels of HDAC6 and reduced the acetylation of α‐tubulin and the stability of microtubules.Abstract : Background: P62 (also named sequestosome‐1, SQSTM1) is involved in autophagy regulation through multiple pathways. It interacts with autophagosomes‐associated LC3‐II and ubiquitinated protein aggregates to engulf the aggregates in autophagosomes, interacts with HDAC6 to inhibit its deacetylase activity to maintain the levels of acetylated α‐tubulin and stabilities of microtubules to enhance autophagosome trafficking, and regulates autophagy initiation and cell survival. We performed immunohistochemistry staining of P62 in prostate tissues from prostate cancer patients and found that levels of P62 in patients with prostate adenocarcinomas (PCA) are significantly higher than those in patients with benign prostate hyperplasia (BPH). High levels of P62 predict high tumor grade and high intensity of metastasis. Methods: We created prostate cancer cell lines stably overexpressing P62 and then suppress the expression of P62 in the cell line stably overexpressing P62 with CRISPR technology. Cell proliferation assay with crystal violet, cell migration assay, cell invasion assay, Western blot analysis, and confocal fluorescent microscopy were conducted to test the impact of altered levels of P62 on the growth, migration, invasion, epithelial‐to‐mesenchymal transition, autophagy flux, HDAC6 activity, and microtubular acetylation of cancer cells. Results: P62 increased the levels of HDAC6 and reduced the acetylation of α‐tubulin and the stability of microtubules. Consequently, high levels of P62 caused a promotion of epithelial‐to‐mesenchymal transition in addition to an impairment of autophagy flux, and further led to an enhancement of proliferation, migration, and invasion of prostate cancer cells. Conclusion: P62 promotes metastasis of PCA by sustaining the level of HDAC6 to inhibit autophagy and promote epithelial‐to‐mesenchymal transition. … (more)
- Is Part Of:
- Prostate. Volume 78:Issue 6(2018)
- Journal:
- Prostate
- Issue:
- Volume 78:Issue 6(2018)
- Issue Display:
- Volume 78, Issue 6 (2018)
- Year:
- 2018
- Volume:
- 78
- Issue:
- 6
- Issue Sort Value:
- 2018-0078-0006-0000
- Page Start:
- 426
- Page End:
- 434
- Publication Date:
- 2018-01-31
- Subjects:
- acetylation -- microtubule -- prognosis -- prostate adenocarcinoma -- SQSTM1
Prostate -- Diseases -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0045 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/pros.23487 ↗
- Languages:
- English
- ISSNs:
- 0270-4137
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6935.194000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5963.xml